rs74315394

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2

The NM_170784.3(MKKS):​c.724G>T​(p.Ala242Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00773 in 1,614,156 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0048 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0080 ( 69 hom. )

Consequence

MKKS
NM_170784.3 missense

Scores

3
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:12

Conservation

PhyloP100: 7.24

Publications

29 publications found
Variant links:
Genes affected
MKKS (HGNC:7108): (MKKS centrosomal shuttling protein) This gene encodes a protein which shares sequence similarity with other members of the type II chaperonin family. The encoded protein is a centrosome-shuttling protein and plays an important role in cytokinesis. This protein also interacts with other type II chaperonin members to form a complex known as the BBSome, which involves ciliary membrane biogenesis. This protein is encoded by a downstream open reading frame (dORF). Several upstream open reading frames (uORFs) have been identified, which repress the translation of the dORF, and two of which can encode small mitochondrial membrane proteins. Mutations in this gene have been observed in patients with Bardet-Biedl syndrome type 6, also known as McKusick-Kaufman syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2023]
MKKS Gene-Disease associations (from GenCC):
  • McKusick-Kaufman syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Bardet-Biedl syndrome 6
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_170784.3
BP4
Computational evidence support a benign effect (MetaRNN=0.013411105).
BP6
Variant 20-10412791-C-A is Benign according to our data. Variant chr20-10412791-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 167303.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MKKSNM_170784.3 linkc.724G>T p.Ala242Ser missense_variant Exon 3 of 6 ENST00000347364.7 NP_740754.1 Q9NPJ1B7Z3W9
MKKSNM_018848.3 linkc.724G>T p.Ala242Ser missense_variant Exon 3 of 6 NP_061336.1 Q9NPJ1B7Z3W9
MKKSNR_072977.2 linkn.347-3988G>T intron_variant Intron 2 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MKKSENST00000347364.7 linkc.724G>T p.Ala242Ser missense_variant Exon 3 of 6 1 NM_170784.3 ENSP00000246062.4 Q9NPJ1
MKKSENST00000399054.6 linkc.724G>T p.Ala242Ser missense_variant Exon 3 of 6 1 ENSP00000382008.2 Q9NPJ1
MKKSENST00000651692.1 linkc.724G>T p.Ala242Ser missense_variant Exon 4 of 7 ENSP00000498849.1 Q9NPJ1
MKKSENST00000652676.1 linkn.459-91G>T intron_variant Intron 3 of 6

Frequencies

GnomAD3 genomes
AF:
0.00483
AC:
735
AN:
152172
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.0548
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00798
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00521
AC:
1308
AN:
251040
AF XY:
0.00500
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00416
Gnomad NFE exome
AF:
0.00969
Gnomad OTH exome
AF:
0.00344
GnomAD4 exome
AF:
0.00803
AC:
11736
AN:
1461866
Hom.:
69
Cov.:
33
AF XY:
0.00766
AC XY:
5568
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00140
AC:
47
AN:
33480
American (AMR)
AF:
0.00188
AC:
84
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00126
AC:
33
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86256
European-Finnish (FIN)
AF:
0.00462
AC:
247
AN:
53418
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00985
AC:
10958
AN:
1111994
Other (OTH)
AF:
0.00596
AC:
360
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
757
1515
2272
3030
3787
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
420
840
1260
1680
2100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00483
AC:
735
AN:
152290
Hom.:
4
Cov.:
32
AF XY:
0.00457
AC XY:
340
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00156
AC:
65
AN:
41570
American (AMR)
AF:
0.00236
AC:
36
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00264
AC:
28
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00798
AC:
543
AN:
68022
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00762
Hom.:
17
Bravo
AF:
0.00476
TwinsUK
AF:
0.00782
AC:
29
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00581
AC:
50
ExAC
AF:
0.00556
AC:
675
EpiCase
AF:
0.00949
EpiControl
AF:
0.00688

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:12
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:6
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MKKS: BS1, BS2 -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 17, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS2, PS3_moderate -

Jan 25, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:4
Apr 18, 2018
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 08, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: MKKS c.724G>T (p.Ala242Ser) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0052 in 251040 control chromosomes in the gnomAD database, including 10 homozygotes. The observed variant frequency is approximately 6.9 fold of the estimated maximal expected allele frequency for a pathogenic variant in MKKS causing Bardet-Biedl Syndrome phenotype (0.00076), strongly suggesting that the variant is benign. Although reported in the literature, to our knowledge, no penetrant association of c.724G>T in individuals affected with Bardet-Biedl Syndrome/McKusick-Kaufman syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments and a majority consensus as benign/likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -

Jan 10, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

McKusick-Kaufman syndrome Uncertain:1Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Aug 22, 2023
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome;C0948368:McKusick-Kaufman syndrome Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.092
T
BayesDel_noAF
Uncertain
0.11
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.78
D;D
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.67
.;T
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.013
T;T
MetaSVM
Uncertain
0.19
D
MutationAssessor
Uncertain
2.8
M;M
PhyloP100
7.2
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-2.3
N;N
REVEL
Pathogenic
0.68
Sift
Uncertain
0.025
D;D
Sift4G
Uncertain
0.045
D;D
Polyphen
0.99
D;D
Vest4
0.54
MVP
0.92
MPC
0.47
ClinPred
0.033
T
GERP RS
5.7
Varity_R
0.32
gMVP
0.64
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74315394; hg19: chr20-10393439; COSMIC: COSV100726345; COSMIC: COSV100726345; API